EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,018,786 | -62.0% | 299,643 | -17.9% | 0.00% | -50.0% |
Q2 2023 | $2,681,207 | -27.5% | 364,790 | +0.5% | 0.00% | -33.3% |
Q1 2023 | $3,696,582 | -15.0% | 363,122 | -1.3% | 0.00% | -25.0% |
Q4 2022 | $4,347,096 | -39.7% | 368,086 | +7.2% | 0.00% | -33.3% |
Q3 2022 | $7,204,000 | -28.6% | 343,218 | +5.7% | 0.01% | -25.0% |
Q2 2022 | $10,084,000 | +21.4% | 324,861 | +60.5% | 0.01% | +33.3% |
Q1 2022 | $8,308,000 | +20.3% | 202,346 | +27.4% | 0.01% | +50.0% |
Q4 2021 | $6,906,000 | +186.7% | 158,875 | +230.2% | 0.00% | +100.0% |
Q3 2021 | $2,409,000 | -23.7% | 48,116 | -4.0% | 0.00% | 0.0% |
Q2 2021 | $3,158,000 | -19.8% | 50,140 | +18.3% | 0.00% | -33.3% |
Q1 2021 | $3,937,000 | +1408.4% | 42,379 | +1353.8% | 0.00% | – |
Q4 2020 | $261,000 | -77.6% | 2,915 | -74.2% | 0.00% | -100.0% |
Q3 2020 | $1,166,000 | -43.8% | 11,282 | -70.6% | 0.00% | -50.0% |
Q4 2019 | $2,073,000 | -50.3% | 38,419 | -51.8% | 0.00% | -50.0% |
Q3 2019 | $4,167,000 | -20.4% | 79,711 | -9.7% | 0.00% | -33.3% |
Q4 2018 | $5,234,000 | +18.8% | 88,286 | +31.9% | 0.01% | +50.0% |
Q3 2018 | $4,407,000 | +0.4% | 66,952 | -23.0% | 0.00% | 0.0% |
Q2 2018 | $4,388,000 | +377.0% | 86,916 | +397.5% | 0.00% | +300.0% |
Q1 2018 | $920,000 | +16.6% | 17,471 | +2.9% | 0.00% | 0.0% |
Q4 2017 | $789,000 | -84.5% | 16,981 | -90.6% | 0.00% | -83.3% |
Q2 2016 | $5,078,000 | -21.5% | 180,590 | +1.4% | 0.01% | -25.0% |
Q1 2016 | $6,472,000 | -6.4% | 178,057 | +3.0% | 0.01% | 0.0% |
Q4 2015 | $6,915,000 | +19.0% | 172,828 | -15.2% | 0.01% | +14.3% |
Q3 2015 | $5,810,000 | -3.0% | 203,918 | +12.1% | 0.01% | 0.0% |
Q2 2015 | $5,992,000 | +19.7% | 181,854 | +4.5% | 0.01% | +16.7% |
Q1 2015 | $5,006,000 | -4.3% | 174,059 | -9.4% | 0.01% | 0.0% |
Q4 2014 | $5,230,000 | +27.8% | 192,066 | +0.0% | 0.01% | +20.0% |
Q3 2014 | $4,093,000 | +3.2% | 192,060 | +8.7% | 0.01% | 0.0% |
Q2 2014 | $3,968,000 | -6.2% | 176,689 | +5.6% | 0.01% | 0.0% |
Q1 2014 | $4,229,000 | +186.9% | 167,371 | +161.0% | 0.01% | +150.0% |
Q4 2013 | $1,474,000 | – | 64,119 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |